EN2 and cancer: We analyzed the enriched KEGG pathway associations of EN2 and EN2 treated with Selitrectinib (Supplementary Table S5), while EN2 interactome is associated with many cancer-related pathways, almost all these associations are lost after treatment with Selitrectinib.